Tmunity, which is being acquired by Gilead's Kite, suffered a major setback last year when two patients died in a clinical trial testing the company's prostate cancer cell therapy.
Tmunity, which is being acquired by Gilead's Kite, suffered a major setback last year when two patients died in a clinical trial testing the company's prostate cancer cell therapy.
